Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Effects of denosumab reported in patients with prostate cancer and bone metastases

Nov. 2, 2010

Clinical trials explore efficacy of budesonide in treating eosinophilic esophagitis

Nov. 2, 2010

Data from several studies on mitoxantrone for relapsing-remitting MS made available

Nov. 2, 2010

Rifaximin-EIR induces durable remissions in patients with Crohn's disease

Oct. 29, 2010

BETAPEDIC trial of IFN-beta-1b in juvenile patients with MS is enrolling participants

Oct. 29, 2010

AR-452530 and AR-460770 reduce symptoms of EAE in vivo

Oct. 29, 2010

Combination of WX-671 and gemcitabine shows promise in phase II trial in pancreatic cancer

Oct. 29, 2010

Fampridine therapy increases walking speed of patients with MS in phase II/III trials

Oct. 29, 2010

BMPR-1A inhibition by RAP-661 increases bone mass and strength in mice

Oct. 28, 2010

Intravenous zanamivir administration is feasible in patients with severe flu

Oct. 28, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...